RNF2 and triple-negative breast carcinoma: Mechanistically, RING1B associates with specific cPRC1 components that are recruited to enhancers containing estrogen receptor alpha (ERα) in ER+ cells, and to BRD4-containing enhancers in triple-negative breast cancer (TNBC) cells.